Publications by authors named "C L Salom"
Background: Examining take-home naloxone (THN) uptake using a 'cascade of care' framework could help identify targets for increasing THN training and carriage among people who may witness or experience opioid overdose. We describe the THN cascade and factors associated with engagement among people who inject drugs.
Methods: People aged ≥18 years in Australia who inject drugs were interviewed from 2020 to 2022, reporting lifetime THN awareness and acquisition and past-month carriage.
Introduction: People who inject drugs experience stigma across multiple settings, including when accessing health-care services, however, comparatively little is known about experiences of stigma towards other groups of people who use illegal drugs. This paper examines experience of, and factors associated with, stigma among two samples of people who use illegal drugs when visiting both specialist alcohol and other drug (AOD) and general health-care services.
Methods: Australians who regularly (i.
The purpose of the study was to determine the impact of weight loss through calorie restriction on metabolic profile, and inflammatory and oxidative stress parameters in metabolically healthy (MHO) and unhealthy (MUHO) obese individuals. A total of 74 subjects (34 MHO and 40 MUHO) received two cycles of a very low-calorie diet, alternating with a hypocaloric diet for 24 weeks. Biochemical, oxidative stress, and inflammatory markers, as well as serum metabolomic analysis by nuclear magnetic resonance, were performed at baseline and at the end of the intervention.
View Article and Find Full Text PDFArticle Synopsis
- A study was conducted in Australia to assess COVID-19 vaccine coverage and the motivations and barriers to vaccination among people who inject drugs, finding that 84.1% had received at least one dose.
- Key motivations for vaccination included personal and community protection; mistrust in vaccines and government were significant barriers.
- Factors associated with receiving higher doses included opioid agonist treatment, current influenza vaccination, stable housing, and being aged 40 or older or having a chronic health condition.
Article Synopsis
- * The study analyzed 10 years of survey data (2012-2022) to identify five polysubstance use profiles and found a significant decline in opioid-depressant use, correlating with reduced pharmaceutical opioid usage and treatment, while single drug class use increased.
- * Various polysubstance use profiles showed associations with psychosocial issues like unstable housing and high psychological distress, along with risky behaviors such as needle sharing and non-fatal overdoses, highlighting the complex nature of